CD4 and pneumocystosis: Among the 68 patients who discontinued primary prophylaxis after CD4 counts increased to ≧200 cells/μL, 1 case of pneumocystosis was diagnosed with an incidence rate of 0.43 per 100 PY (95% CI, 0.01 to 2.38).